AAO: Sequential nonarteritic anterior ischemic optic neuropathy occurs earlier with GLP-1 receptor agonist exposure
For patients with nonarteritic anterior ischemic optic neuropathy (NAION), glucagon-like peptide-1 (GLP-1) receptor agonist exposure is associated with earlier sequential NAION, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held Oct. 9 to 12 in New Orleans.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Canada's youngest generation is off to a healthy start, but screen time is a challenge
United Kingdom
-
Beef can fit into healthy diets, but what about its environmental cost?
United Kingdom
-
Semaglutide and teduglutide reduce immune-driven gut injury in mice
United Kingdom
-
Eye tracking could help virtual reality pain therapy adapt to individual needs
United Kingdom
-
Attacks on water systems are attacks on health, say experts
United Kingdom
-
Use green transition funds to achieve health for all, suggest experts
United Kingdom
-
Is all screen time bad for children? Maybe not, new review suggests
United Kingdom
-
One tooth, six clues: How a single tooth can help in identifying deceased persons
United Kingdom